This is in accordance with two recently published reports describing (i) a small de novo deletion within ARID1B in a patient with autism (15) and (ii) a patient with ACC, intellectual disability, speech impairment, and autism, in which a de novo translocation disrupted two genes: ARID1B and MRPP3(16). This evidence concerns the gene PRORP and adrenal cortex carcinoma.